Clin2
NCT07306260Possibly a fitRecruiting

Photodynamic therapy for cervical pre-cancer

HSIL, High Grade Squamous Intraepithelial LesionCIN 2HPV (Human Papillomavirus)-AssociatedPhotodynamic Therapy (PDT)

Part of Infections clinical trials.

This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
560 people
Ages
25 years to 65 years
Study type
Interventional

Who can take part

  • You are female and between the ages of 25 and 60.
  • A biopsy taken within the last 3 months must show cervical pre-cancer (CIN2).
  • You are not pregnant or breastfeeding.
  • You have not had cervical surgery or treatment for cervical cancer in the last 6 months.
  • You are willing to give written consent to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07306247Not yet recruiting
Light therapy for low-grade cervical changes with HPV 16 or 18

This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.

Hangzhou, Zhejiang
NCT07669363Not yet recruiting· Phase 2
Light therapy before surgery for cervical precancer

This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.

Fuzhou, Fujian
NCT07634497Not yet recruiting
Light therapy for cervical precancerous changes

This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.

NCT06982976Recruiting
Light therapy for abnormal cervical or vaginal cells

This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.

Beijing, Beijing Municipality
NCT07009327Recruiting
Photodynamic therapy for CIN3

This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.

Beijing
NCT06052033Recruiting
Light therapy vs. laser for persistent cervical changes with HPV

This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.

Wenzhou, Zhejiang

Hear when a new HPV (Human Papillomavirus)-Associated trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.